Unsurprisingly, the cutaneous form is the most widely studied, with various degrees of positive KIT labeling on immunohistochemistry (IHC) in 168/208 (81%; range: 55–93%) tumor samples across all reviewed studies [62,63,64,69,70,71]. Here, KIT is linked to neoplasm.